Advances in quantitative structure–activity relationship models of antimalarials

By Roy Kunal   Ojha Probir Kumar  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 8, 2010-08 ,pp. : 751-778

Informa Healthcare

Access to resources Recommend Favorite

Advances in quantitative structure–activity relationship models of anti-Alzheimer’s agents

By Ambure Pravin   Roy Kunal  

Expert Opinion on Drug Discovery, Vol. 9, Iss. 6, 2014-06 ,pp. : 697-723

Informa Healthcare

Access to resources Recommend Favorite

Advances in the molecular modeling and quantitative structure–activity relationship-based design for antihistamines

By Galvez Jorge   Galvez-Llompart Maria   Zanni Riccardo   Garcia-Domenech Ramon  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 3, 2013-03 ,pp. : 305-317

Informa Healthcare

Access to resources Recommend Favorite

On some aspects of validation of predictive quantitative structure–activity relationship models

By Roy Kunal  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 12, 2007-12 ,pp. : 1567-1577

Informa Healthcare

Access to resources Recommend Favorite

Quantitative Structure-Activity Relationship Studies on Cholecystokinin Antagonists

By  

Current Pharmaceutical Design, Vol. 8, Iss. 2, 2002-01 ,pp. : 111-124

Bentham Science Publishers

Access to resources Recommend Favorite